Centene (NYSE:CNC) Issues FY 2026 Earnings Guidance

by · The Cerbat Gem

Centene (NYSE:CNCGet Free Report) updated its FY 2026 earnings guidance on Thursday. The company provided EPS guidance of 3.000- for the period, compared to the consensus EPS estimate of 2.990. The company issued revenue guidance of -.

Analyst Ratings Changes

Several research firms have weighed in on CNC. Morgan Stanley boosted their price target on Centene from $38.00 to $45.00 and gave the stock an “equal weight” rating in a research report on Wednesday, March 4th. Sanford C. Bernstein reaffirmed an “outperform” rating and set a $59.00 price target on shares of Centene in a research report on Tuesday, January 6th. Weiss Ratings reaffirmed a “sell (d)” rating on shares of Centene in a research report on Wednesday, January 21st. Wells Fargo & Company set a $44.00 target price on Centene and gave the stock an “equal weight” rating in a research note on Wednesday, February 18th. Finally, Jefferies Financial Group reduced their target price on Centene from $43.00 to $37.00 and set a “hold” rating for the company in a research note on Friday, February 13th. Three equities research analysts have rated the stock with a Buy rating, fourteen have assigned a Hold rating and three have assigned a Sell rating to the company. Based on data from MarketBeat.com, Centene currently has an average rating of “Hold” and an average target price of $41.81.

Read Our Latest Stock Report on Centene

Centene Stock Performance

CNC traded down $0.37 during trading on Friday, hitting $37.18. The stock had a trading volume of 88,683 shares, compared to its average volume of 6,527,514. The company has a 50 day moving average price of $38.66 and a 200-day moving average price of $38.84. The firm has a market cap of $18.29 billion, a price-to-earnings ratio of -2.72, a P/E/G ratio of 0.83 and a beta of 0.59. Centene has a one year low of $25.08 and a one year high of $64.15. The company has a debt-to-equity ratio of 0.87, a current ratio of 1.10 and a quick ratio of 1.10.

Centene (NYSE:CNCGet Free Report) last released its quarterly earnings results on Friday, February 6th. The company reported ($1.19) earnings per share (EPS) for the quarter, beating the consensus estimate of ($1.22) by $0.03. The business had revenue of $49.73 billion during the quarter, compared to the consensus estimate of $48.41 billion. Centene had a positive return on equity of 4.25% and a negative net margin of 3.43%.The firm’s quarterly revenue was up 21.9% on a year-over-year basis. During the same period in the previous year, the company posted $0.80 EPS. Centene has set its FY 2026 guidance at 3.000-3.000 EPS. As a group, research analysts predict that Centene will post 6.86 EPS for the current year.

Institutional Trading of Centene

A number of institutional investors have recently modified their holdings of CNC. Baird Financial Group Inc. bought a new stake in shares of Centene during the 1st quarter valued at $236,000. Sivia Capital Partners LLC lifted its position in shares of Centene by 80.0% during the 2nd quarter. Sivia Capital Partners LLC now owns 9,710 shares of the company’s stock valued at $527,000 after acquiring an additional 4,315 shares during the period. CW Advisors LLC lifted its position in shares of Centene by 20.3% during the 2nd quarter. CW Advisors LLC now owns 4,863 shares of the company’s stock worth $264,000 after buying an additional 820 shares during the last quarter. NewEdge Advisors LLC lifted its position in shares of Centene by 6.1% during the 2nd quarter. NewEdge Advisors LLC now owns 44,945 shares of the company’s stock worth $2,440,000 after buying an additional 2,582 shares during the last quarter. Finally, Treasurer of the State of North Carolina lifted its position in shares of Centene by 0.4% during the 2nd quarter. Treasurer of the State of North Carolina now owns 231,938 shares of the company’s stock worth $12,590,000 after buying an additional 967 shares during the last quarter. 93.63% of the stock is currently owned by institutional investors.

About Centene

(Get Free Report)

Centene Corporation (NYSE: CNC) is a diversified, multi-national healthcare enterprise that specializes in providing services to government-sponsored and national health programs. The company primarily acts as a managed care organization, delivering healthcare coverage and administering benefits for Medicaid, the Children’s Health Insurance Program (CHIP), Medicare Advantage, and individual marketplace plans. Centene also contracts with federal and state agencies to manage specialty care programs and community-based services for vulnerable populations.

Centene’s offerings extend beyond traditional insurance to include a range of specialty and support services.

See Also